OEMs, suppliers and thought leaders convene to talk about opportunities and the future of aerospace. ROCHESTER, Mich., June 7, 2022 /PRNewswire/ -- On Sept. 7–8, 2022, Aerospace Industry...

Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing an investigational therapy Haduvio™ (nalbuphine ER) for pruritus in prurigo nodularis (PN) and...

Oral presentation confirms patients achieved clinically meaningful nadir serum asparaginase activity throughout the course of Rylaze treatment with intramuscular dosing regimen administered...

With the 3rd BIO International Convention 2022 soon approaching, Neurophth Therapeutics is looking forward to discussing collaboration opportunities in gene therapy for both rare and common ocular...

Demonstrates first-ever commercial product capable of single-cell RNA sequencing on FFPE tissues Opens preorders for CytAssist, the company's first spatial instrument Shares new data on the...